Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Ralph Weichselbaum
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Procedures
Disorders
Anatomy
Living Beings
Chemicals & Drugs
Physiology
Concepts & Ideas
Phenomena
Sign-in to see full Profile
Network (preview)
70
Vokes, Everett
63
Beckett, Michael
56
Kufe, Donald
52
Haraf, Daniel
42
Mauceri, Helena
34
Hallahan, Dennis
28
Roizman, Bernard
23
Posner, Mitchell
22
Hellman, Samuel
22
Panje, WR
21
Advani, Sunil
20
Khodarev, Nikolai
19
Awan, Azhar M.
15
Vijayakumar, Srinivasan
14
Stenson, Kerstin
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Ralph Weichselbaum (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Uriel Shiri; Labay Edwardine; Francis-Sedlak Megan; Moya Monica L; Weichselbaum Ralph R; Ervin Natalia; Cankova Zdravka; Brey Eric M
Extraction and assembly of tissue-derived gels for cell culture and tissue engineering.
Tissue engineering. Part C, Methods 2009;15(3):309-21.
-
2009: Haney Chad R; Parasca Adrian D; Fan Xiaobing; Bell Rebecca M; Zamora Marta A; Karczmar Gregory S; Mauceri Helena J; Halpern Howard J; Weichselbaum Ralph R; Pelizzari Charles A
Characterization of response to radiation mediated gene therapy by means of multimodality imaging.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2009;62(2):348-56.
-
2009: Weichselbaum R R; Kufe D
Translation of the radio- and chemo-inducible TNFerade vector to the treatment of human cancers.
Cancer gene therapy 2009;16(8):609-19.
-
2009: Cohen Ezra E W; Baru Joshua; Huo Dezheng; Haraf Daniel J; Crowley Maureen; Witt Mary Ellyn; Blair Elizabeth A; Weichselbaum Ralph R; Rosen Fred; Vokes Everett E; Stenson Kerstin
Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy.
Head & neck 2009;31(8):1013-21.
-
2009: Lee Youjin; Auh Sogyong L; Wang Yugang; Burnette Byron; Wang Yang; Meng Yuru; Beckett Michael; Sharma Rohit; Chin Robert; Tu Tony; Weichselbaum Ralph R; Fu Yang-Xin
Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment.
Blood 2009;114(3):589-95.
-
2009: Liauw S L; Weichselbaum R R; Rash C; Correa D; Al-Hallaq H A; Pelizzari C A; Jani A B
Biochemical control and toxicity after intensity-modulated radiation therapy for prostate cancer.
Technology in cancer research & treatment 2009;8(3):201-6.
-
2009: Efimova Elena V; Liang Hua; Pitroda Sean P; Labay Edwardine; Darga Thomas E; Levina Vera; Lokshin Anna; Roizman Bernard; Weichselbaum Ralph R; Khodarev Nikolai N
Radioresistance of Stat1 over-expressing tumour cells is associated with suppressed apoptotic response to cytotoxic agents and increased IL6-IL8 signalling.
International journal of radiation biology 2009;85(5):421-31.
-
2009: Khodarev Nikolai N; Pitroda Sean P; Beckett Michael A; MacDermed Dhara M; Huang Lei; Kufe Donald W; Weichselbaum Ralph R
MUC1-induced transcriptional programs associated with tumorigenesis predict outcome in breast and lung cancer.
Cancer research 2009;69(7):2833-7.
-
2009: Pitroda Sean P; Khodarev Nikolai N; Beckett Michael A; Kufe Donald W; Weichselbaum Ralph R
MUC1-induced alterations in a lipid metabolic gene network predict response of human breast cancers to tamoxifen treatment.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(14):5837-41.
-
2009: Liauw Stanley L; Fricano Janine; Correa David; Weichselbaum Ralph R; Jani Ashesh B
Dose-escalated radiation therapy for intermediate-risk prostate cancer: patient selection for androgen deprivation therapy using percentage of positive cores.
Cancer 2009;115(8):1784-90.
-
2009: Mauceri H J; Beckett M A; Liang H; Sutton H G; Pitroda S; Galka E; Efimova E; Darga T; Khodarev N N; King C R; Posner M C; Hellman S; Kufe D W; Weichselbaum R R
Translational strategies exploiting TNF-alpha that sensitize tumors to radiation therapy.
Cancer gene therapy 2009;16(4):373-81.
-
2009: Gutt Ruchika; Liauw Stanley L; Weichselbaum Ralph R
Adjuvant radiotherapy for resected pancreatic cancer: a lack of benefit or a lack of adequate trials?
Nature clinical practice. Gastroenterology & hepatology 2009;6(1):38-46.
-
2009: Khodarev Nikolai N; Roach Paul; Pitroda Sean P; Golden Daniel W; Bhayani Mihir; Shao Michael Y; Darga Thomas E; Beveridge Mara G; Sood Ravi F; Sutton Harold G; Beckett Michael A; Mauceri Helena J; Posner Mitchell C; Weichselbaum Ralph R
STAT1 pathway mediates amplification of metastatic potential and resistance to therapy.
PloS one 2009;4(6):e5821.
-
2008: Weichselbaum Ralph R
MUCing around with tumor suppression.
Cancer biology & therapy 2008;7(12):1968-9.
-
2008: Weichselbaum Ralph R; Ishwaran Hemant; Yoon Taewon; Nuyten Dimitry S A; Baker Samuel W; Khodarev Nikolai; Su Andy W; Shaikh Arif Y; Roach Paul; Kreike Bas; Roizman Bernard; Bergh Jonas; Pawitan Yudi; van de Vijver Marc J; Minn Andy J
An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(47):18490-5.
-
2008: Al-Hallaq Hania A; Mell Loren K; Bradley Julie A; Chen Lucy F; Ali Arif N; Weichselbaum Ralph R; Newstead Gillian M; Chmura Steven J
Magnetic resonance imaging identifies multifocal and multicentric disease in breast cancer patients who are eligible for partial breast irradiation.
Cancer 2008;113(9):2408-14.
-
2008: Jayathilaka Krishanthi; Sheridan Sean D; Bold Tyler D; Bochenska Katarzyna; Logan Hillary L; Weichselbaum Ralph R; Bishop Douglas K; Connell Philip P
A chemical compound that stimulates the human homologous recombination protein RAD51.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(41):15848-53.
-
2008: Macdermed Dhara M; Weichselbaum Ralph R; Salama Joseph K
A rationale for the targeted treatment of oligometastases with radiotherapy.
Journal of surgical oncology 2008;98(3):202-6.
-
2008: Salama Joseph K; Chmura Steven J; Mehta Neil; Yenice Kamil M; Stadler Walter M; Vokes Everett E; Haraf Daniel J; Hellman Samuel; Weichselbaum Ralph R
An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(16):5255-9.
-
2008: Liauw Stanley L; Weichselbaum Ralph R; Zagaja Gregory P; Jani Ashesh B
Salvage radiotherapy after postprostatectomy biochemical failure: does pretreatment radioimmunoscintigraphy help select patients with locally confined disease?
International journal of radiation oncology, biology, physics 2008;71(5):1316-21.
-
2008: Seiwert Tanguy Y; Haraf Daniel J; Cohen Ezra E W; Stenson Kerstin; Witt Mary Ellyn; Dekker Allison; Kocherginsky Masha; Weichselbaum Ralph R; Chen Helen X; Vokes Everett E
Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(10):1732-41.
-
2008: Bickenbach K A; Veerapong J; Shao M Y; Mauceri H J; Posner M C; Kron S J; Weichselbaum R R
Resveratrol is an effective inducer of CArG-driven TNF-alpha gene therapy.
Cancer gene therapy 2008;15(3):133-9.
-
2007: Katdare Mukta; Efimova Elena V; Labay Edwardine; Khodarev Nikolai N; Darga Thomas E; Garofalo Michael; Nakamura Satoaki; Kufe Donald W; Posner Mitchell C; Weichselbaum Ralph R
Diverse TNFalpha-induced death pathways are enhanced by inhibition of NF-kappaB.
International journal of oncology 2007;31(6):1519-28.
-
2007: Mell Loren K; Weichselbaum Ralph R
More on cetuximab in head and neck cancer.
The New England journal of medicine 2007;357(21):2201-2; author reply 2202-3.
-
2007: Yamini Bakhtiar; Yu Xiaohong; Pytel Peter; Galanopoulos Nicholas; Rawlani Vinay; Veerapong Jula; Bickenbach Kai; Weichselbaum Ralph R
Adenovirally delivered tumor necrosis factor-alpha improves the antiglioma efficacy of concomitant radiation and temozolomide therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(20):6217-23.
-
2007: Smith Kerrington D; Shao Michael Y; Posner Mitchell C; Weichselbaum Ralph R
Tumor genotype determines susceptibility to oncolytic herpes simplex virus mutants: strategies for clinical application.
Future oncology (London, England) 2007;3(5):545-56.
-
2007: Khodarev Nikolai N; Minn Andy J; Efimova Elena V; Darga Thomas E; Labay Edwardine; Beckett Michael; Mauceri Helena J; Roizman Bernard; Weichselbaum Ralph R
Signal transducer and activator of transcription 1 regulates both cytotoxic and prosurvival functions in tumor cells.
Cancer research 2007;67(19):9214-20.
-
2007: Roeske John C; Nunez Luis; Hoggarth Mark; Labay Edwardine; Weichselbaum Ralph R
Characterization of the theorectical radiation dose enhancement from nanoparticles.
Technology in cancer research & treatment 2007;6(5):395-401.
-
2007: Advani Sunil J; Weichselbaum Ralph R; Chmura Steven J
Enhancing radiotherapy with genetically engineered viruses.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(26):4090-5.
-
2007: Veerapong Jula; Bickenbach Kai A; Shao Michael Y; Smith Kerrington D; Posner Mitchell C; Roizman Bernard; Weichselbaum Ralph R
Systemic delivery of (gamma1)34.5-deleted herpes simplex virus-1 selectively targets and treats distant human xenograft tumors that express high MEK activity.
Cancer research 2007;67(17):8301-6.
-
2007: Sharma Rohit R; Weichselbaum Ralph R
Angiogenesis inhibition: the next frontier in multimodal therapy for glioblastoma multiforme.
Nature clinical practice. Oncology 2007;4(8):454-5.
-
2007: Yamini Bakhtiar; Yu Xiaohong; Dolan M Eileen; Wu Michael H; Darga Thomas E; Kufe Donald W; Weichselbaum Ralph R
Inhibition of nuclear factor-kappaB activity by temozolomide involves O6-methylguanine induced inhibition of p65 DNA binding.
Cancer research 2007;67(14):6889-98.
-
2007: Skelly Christopher L; Chandiwal Amito; Vosicky James E; Weichselbaum Ralph R; Roizman Bernard
Attenuated herpes simplex virus 1 blocks arterial apoptosis and intimal hyperplasia induced by balloon angioplasty and reduced blood flow.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(30):12474-8.
-
2007: Zhang Bin; Bowerman Natalie A; Salama Joseph K; Schmidt Hank; Spiotto Michael T; Schietinger Andrea; Yu Ping; Fu Yang-Xin; Weichselbaum Ralph R; Rowley Donald A; Kranz David M; Schreiber Hans
Induced sensitization of tumor stroma leads to eradication of established cancer by T cells.
The Journal of experimental medicine 2007;204(1):49-55.
-
2007: MacGill Randall S; Davis Thomas A; Macko Jennifer; Mauceri Helena J; Weichselbaum Ralph R; King C Richter
Local gene delivery of tumor necrosis factor alpha can impact primary tumor growth and metastases through a host-mediated response.
Clinical & experimental metastasis 2007;24(7):521-31.
-
2006: Mezhir James J; Smith Kerrington D; Kimchi Eric T; Park James O; Lopez Carlos A; Mauceri Helena J; Beckett Micheal A; Hellman Samual; Weichselbaum Ralph R; Posner Mitchell C
Establishment of a syngeneic model of hepatic colorectal oligometastases.
The Journal of surgical research 2006;136(2):288-93.
-
2006: Advani Sunil J; Mezhir James J; Roizman Bernard; Weichselbaum Ralph R
ReVOLT: radiation-enhanced viral oncolytic therapy.
International journal of radiation oncology, biology, physics 2006;66(3):637-46.
-
2006: Kao J; Milano M T; Javaheri A; Garofalo M C; Chmura S J; Weichselbaum R R; Kron S J
gamma-H2AX as a therapeutic target for improving the efficacy of radiation therapy.
Current cancer drug targets 2006;6(3):197-205.
-
2006: Jani Ashesh B; Feinstein Jeffrey M; Pasciak Robert; Krengel Samuel; Weichselbaum Ralph R
Role of external beam radiotherapy with low-dose-rate brachytherapy in treatment of prostate cancer.
Urology 2006;67(5):1007-11.
-
2006: Milano Michael T; Vokes Everett E; Kao Johnny; Jackson Wells; List Marcy A; Stenson Kerstin M; Witt Mary Ellyn; Dekker Allison; MacCracken Ellen; Garofalo Michael C; Chmura Steven J; Weichselbaum Ralph R; Haraf Daniel J
Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions.
International journal of oncology 2006;28(5):1141-51.
-
2006: Connell Philip P; Jayathilaka Krishanthi; Haraf Daniel J; Weichselbaum Ralph R; Vokes Everett E; Lingen Mark W
Pilot study examining tumor expression of RAD51 and clinical outcomes in human head cancers.
International journal of oncology 2006;28(5):1113-9.
-
2006: Smith Kerrington D; Mezhir James J; Bickenbach Kai; Veerapong Jula; Charron Jean; Posner Mitchell C; Roizman Bernard; Weichselbaum Ralph R
Activated MEK suppresses activation of PKR and enables efficient replication and in vivo oncolysis by Deltagamma(1)34.5 mutants of herpes simplex virus 1.
Journal of virology 2006;80(3):1110-20.
-
2006: Mezhir J J; Smith K D; Posner M C; Senzer N; Yamini B; Kufe D W; Weichselbaum R R
Ionizing radiation: a genetic switch for cancer therapy.
Cancer gene therapy 2006;13(1):1-6.
-
2005: Mezhir James J; Schmidt Hank; Yamini Bakhtiar; Senzer Neil N; Posner Mitchell C; Kufe Donald W; Weichselbaum Ralph R
Chemo-inducible gene therapy.
Anti-cancer drugs 2005;16(10):1053-8.
-
2005: Mezhir James J; Advani Sunil J; Smith Kerrington D; Darga Thomas E; Poon Alice P W; Schmidt Hank; Posner Mitchell C; Roizman Bernard; Weichselbaum Ralph R
Ionizing radiation activates late herpes simplex virus 1 promoters via the p38 pathway in tumors treated with oncolytic viruses.
Cancer research 2005;65(20):9479-84.
-
2005: Weichselbaum Ralph R
Bugging the intestinal response to radiation.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(38):13363-4.
-
2005: Murphy Kevin T; Wardak Abdullah; Beckett Michael A; Lopez Carlos A; Mehta Neil; Kimchi Eric; Salloum Rabih M; Jaskowiak Nora T; Posner Mitchell C; Ohno Tsuneya; Kufe Donald W; Weichselbaum Ralph R; Mauceri Helena J
Forphenicinol enhances the antitumor effects of cyclophosphamide in a model of squamous cell carcinoma.
Cancer chemotherapy and pharmacology 2005;56(3):317-21.
-
2005: Weichselbaum Ralph R
How does antiangiogenic therapy affect brain tumor response to radiation?
Nature clinical practice. Oncology 2005;2(5):232-3.
-
2005: Kimchi Erik T; Posner Mitchell C; Park James O; Darga Thomas E; Kocherginsky Masha; Karrison Theodore; Hart John; Smith Kerrington D; Mezhir James J; Weichselbaum Ralph R; Khodarev Nikolai N
Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.
Cancer research 2005;65(8):3146-54.
-
2005: Milano Michael T; Vokes Everett E; Salama Joseph K; Stenson Kerstin M; Kao Johnny; Witt Mary-Ellyn; Mittal Bharat B; Argiris Athanassios; Weichselbaum Ralph R; Haraf Daniel J
Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy.
International journal of radiation oncology, biology, physics 2005;61(4):1096-106.
-
2005: Hellman Samuel; Weichselbaum Ralph R
Importance of local control in an era of systemic therapy.
Nature clinical practice. Oncology 2005;2(2):60-1.
-
2005: Baldwin Zachary K; Chandiwal Amito; Balasubramanian Viji; Pearce Benjamin J; Curi Michael A; Skelly Christopher L; Huang Wendy W; Vosicky James E; Roizman Bernard; Weichselbaum Ralph R; Schwartz Lewis B
Modulation of vascular remodeling induced by a brief intraluminal exposure to the recombinant R7020 strain of Herpes simplex-1.
Journal of vascular surgery : official publication, the Society for Vascular Surgery [and] International Society for Cardiovascular Surgery, North American Chapter 2005;41(1):115-21.
-
2004: Mehta Neil; Mauer Ann M; Hellman Samuel; Haraf Daniel J; Cohen Ezra E W; Vokes Everett E; Weichselbaum Ralph R
Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment.
International journal of oncology 2004;25(6):1677-83.
-
2004: Khodarev Nikolai N; Kataoka Yasushi; Murley Jeffrey S; Weichselbaum Ralph R; Grdina David J
Interaction of amifostine and ionizing radiation on transcriptional patterns of apoptotic genes expressed in human microvascular endothelial cells (HMEC).
International journal of radiation oncology, biology, physics 2004;60(2):553-63.
-
2004: Yamini Bakhtiar; Yu Xiaohong; Gillespie G Yancey; Kufe Donald W; Weichselbaum Ralph R
Transcriptional targeting of adenovirally delivered tumor necrosis factor alpha by temozolomide in experimental glioblastoma.
Cancer research 2004;64(18):6381-4.
-
2004: Lopez Carlos A; Kimchi Eric T; Mauceri Helena J; Park James O; Mehta Neil; Murphy Kevin T; Beckett Michael A; Hellman Samuel; Posner Mitchell C; Kufe Donald W; Weichselbaum Ralph R
Chemoinducible gene therapy: a strategy to enhance doxorubicin antitumor activity.
Molecular cancer therapeutics 2004;3(9):1167-75.
-
2004: Mundt Arno J; Vijayakumar Srinivasan; Nemunaitis John; Sandler Alan; Schwartz Herbert; Hanna Nader; Peabody Terrence; Senzer Neil; Chu Karen; Rasmussen Camilla S; Kessler Paul D; Rasmussen Henrik S; Warso Michael; Kufe Donald W; Gupta Tapas Das; Weichselbaum Ralph R
A Phase I trial of TNFerade biologic in patients with soft tissue sarcoma in the extremities.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(17):5747-53.
-
2004: Greenebaum Ben; Blossfield Katie; Hannig Jurgen; Carrillo Cinthya S; Beckett Michael A; Weichselbaum Ralph R; Lee Raphael C
Poloxamer 188 prevents acute necrosis of adult skeletal muscle cells following high-dose irradiation.
Burns : journal of the International Society for Burn Injuries 2004;30(6):539-47.
-
2004: Jani Ashesh B; Blend Michael J; Hamilton Russell; Brendler Charles; Pelizzari Charles; Krauz Lani; Sapra Bipin; Vijayakumar Srinivasan; Awan Azhar; Weichselbaum Ralph R
Radioimmunoscintigraphy for postprostatectomy radiotherapy: analysis of toxicity and biochemical control.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(8):1315-22.
-
2004: Connell Philip P; Kron Stephen J; Weichselbaum Ralph R
Relevance and irrelevance of DNA damage response to radiotherapy.
DNA repair 2004;3(8-9):1245-51.
-
2004: Brown Charles K; Khodarev Nikolai N; Yu Jianqing; Moo-Young Tricia; Labay Edwardine; Darga Thomas E; Posner Mitchell C; Weichselbaum Ralph R; Mauceri Helena J
Glioblastoma cells block radiation-induced programmed cell death of endothelial cells.
FEBS letters 2004;565(1-3):167-70.
-
2004: Connell Philip P; Siddiqui Nazli; Hoffman Sara; Kuang Audrey; Khatipov Emir-Assan; Weichselbaum Ralph R; Bishop Douglas K
A hot spot for RAD51C interactions revealed by a peptide that sensitizes cells to cisplatin.
Cancer research 2004;64(9):3002-5.
-
2004: Jani Ashesh B; Blend Michael J; Hamilton Russell; Brendler Charles; Pelizzari Charles; Krauz Lani; Vijayakumar Srinivasan; Sapra Bipin; Awan Azhar; Weichselbaum Ralph R
Influence of radioimmunoscintigraphy on postprostatectomy radiotherapy treatment decision making.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(4):571-8.
-
2004: Lopez Carlos A; Park James O; Mauceri Helena J; Beckett Michael A; Weichselbaum Ralph R; Posner Mitchell C
Control of gene therapy by MDR1 and EGR1 promoter sequences in transcriptional targeting by chemotherapy (Review).
International journal of oncology 2004;24(3):731-6.
-
2004: Khodarev Nikolai N; Labay Edwardine; Darga Thomas; Yu Jianqing; Mauceri Helena; Gupta Nalin; Kataoka Yasushi; Weichselbaum Ralph R
Endothelial cells co-cultured with wild-type and dominant/negative p53-transfected glioblastoma cells exhibit differential sensitivity to radiation-induced apoptosis.
International journal of cancer. Journal international du cancer 2004;109(2):214-9.
-
2004: Jani Ashesh B; Spelbring Danny; Hamilton Russell; Blend Michael J; Pelizzari Charles; Brendler Charles; Krauz Lani; Vijayakumar Srinivasan; Sapra Bipin; Weichselbaum Ralph R
Impact of radioimmunoscintigraphy on definition of clinical target volume for radiotherapy after prostatectomy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(2):238-46.
-
2004: Khodarev Nikolai N; Beckett Michael; Labay Edwardine; Darga Thomas; Roizman Bernard; Weichselbaum Ralph R
STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(6):1714-9.
-
2004: Taneja Neelam; Davis Mandel; Choy John S; Beckett Michael A; Singh Rachana; Kron Stephen J; Weichselbaum Ralph R
Histone H2AX phosphorylation as a predictor of radiosensitivity and target for radiotherapy.
The Journal of biological chemistry 2004;279(3):2273-80.
-
2003: Haraf Daniel J; Rosen Fred R; Stenson Kerstin; Argiris Athanassios; Mittal Bharat B; Witt Mary Ellyn; Brockstein Bruce E; List Marcy A; Portugal Louis; Pelzer Harold; Weichselbaum Ralph R; Vokes Everett E
Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(16 Pt 1):5936-43.
-
2003: Advani Sunil J; Durand Lizette O; Weichselbaum Ralph R; Roizman Bernard
Oct-1 is posttranslationally modified and exhibits reduced capacity to bind cognate sites at late times after infection with herpes simplex virus 1.
Journal of virology 2003;77(22):11927-32.
-
2003: Bartelink Harry; Benz Christopher; Cleveland Don; Dorn Ronald; Gralow Julie; Gradishar William J; Grant Kathleen; Heimann Ruth; Hellman Samuel; Hudis Clifford; Kerbel Robert; Lippman Marc; Lung John; Posner Mitchell C; Steeg Patricia; Vestal Robert; Weichselbaum Ralph R; Zetter Bruce
Expedition Inspiration Fund for Breast Cancer Research Meeting 2003.
Breast cancer research and treatment 2003;80(2):139-44.
-
2003: Connell Philip P; Weichselbaum Ralph R
Gene therapy: the challenges of translating laboratory research into clinical practice.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(12):2230-1.
-
2003: Curi Michael A; Skelly Christopher L; Meyerson Shari L; Baldwin Zachary K; Balasubramanian Viji; Advani Sunil J; Glagov Seymour; Roizman Bernard; Weichselbaum Ralph R; Schwartz Lewis B
Sustained inhibition of experimental neointimal hyperplasia with a genetically modified herpes simplex virus.
Journal of vascular surgery : official publication, the Society for Vascular Surgery [and] International Society for Cardiovascular Surgery, North American Chapter 2003;37(6):1294-300.
-
2003: Rosen Fred R; Haraf Daniel J; Kies Merrill S; Stenson Kerstin; Portugal Louis; List Marcy A; Brockstein Bruce E; Mittal Bharat B; Rademaker Alfred W; Witt Mary Ellyn; Pelzer Harold; Weichselbaum Ralph R; Vokes Everett E
Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(5):1689-97.
-
2003: Advani Sunil J; Weichselbaum Ralph R; Roizman Bernard
Herpes simplex virus 1 activates cdc2 to recruit topoisomerase II alpha for post-DNA synthesis expression of late genes.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(8):4825-30.
-
2003: Oh J L; Vokes E E; Kies M S; Mittal B B; Witt M E; Weichselbaum R R; Haraf D J
Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(4):564-9.
-
2003: Khodarev Nikolai N; Yu Jianqing; Labay Edwardine; Darga Thomas; Brown Charles K; Mauceri Helena J; Yassari Reza; Gupta Nalin; Weichselbaum Ralph R
Tumour-endothelium interactions in co-culture: coordinated changes of gene expression profiles and phenotypic properties of endothelial cells.
Journal of cell science 2003;116(Pt 6):1013-22.
-
2003: Khodarev Nikolai N; Park James; Kataoka Yasushi; Nodzenski Edwardine; Hellman Samuel; Roizman Bernard; Weichselbaum Ralph R; Pelizzari Charles A
Receiver operating characteristic analysis: a general tool for DNA array data filtration and performance estimation.
Genomics 2003;81(2):202-9.
-
2003: Gupta V K; Park J O; Kurihara T; Koons A; Mauceri H J; Jaskowiak N T; Kufe D W; Weichselbaum R R; Posner M C
Selective gene expression using a DF3/MUC1 promoter in a human esophageal adenocarcinoma model.
Gene therapy 2003;10(3):206-12.
-
2003: Salloum Rabih M; Saunders Mark P; Mauceri Helena J; Hanna Nader N; Gorski David H; Posner Mitchell C; Stratford Ian J; Weichselbaum Ralph R
Dual induction of the Epo-Egr-TNF-alpha- plasmid in hypoxic human colon adenocarcinoma produces tumor growth delay.
The American surgeon 2003;69(1):24-7.
-
2003: Gorski David H; Mauceri Helena J; Salloum Rabih M; Halpern Arielle; Seetharam Saraswathy; Weichselbaum Ralph R
Prolonged treatment with angiostatin reduces metastatic burden during radiation therapy.
Cancer research 2003;63(2):308-11.
-
2003: Vokes Everett E; Stenson Kerstin; Rosen Fred R; Kies Merrill S; Rademaker Alfred W; Witt Mary Ellyn; Brockstein Bruce E; List Marcy A; Fung Bing Bing; Portugal Louis; Mittal Bharat B; Pelzer Harold; Weichselbaum Ralph R; Haraf Daniel J
Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(2):320-6.
-
2002: Grdina David J; Kataoka Yasushi; Murley Jeffrey S; Swedberg Kirsten; Lee John Y; Hunter Nancy; Weichselbaum Ralph R; Milas Luka
Antimetastatic effectiveness of amifostine therapy following surgical removal of Sa-NH tumors in mice.
Seminars in oncology 2002;29(6 Suppl 19):22-8.
-
2002: Mauceri Helena J; Seetharam Saraswathy; Beckett Michael A; Schumm L Philip; Koons Ann; Gupta Vinay K; Park James O; Manan Abdullah; Lee John Y; Montag Anthony G; Kufe Donald W; Weichselbaum Ralph R
Angiostatin potentiates cyclophosphamide treatment of metastatic disease.
Cancer chemotherapy and pharmacology 2002;50(5):412-8.
-
2002: Weichselbaum Ralph R; Kufe Donald W; Hellman Samuel; Rasmussen Henrik S; King C Richter; Fischer Paul H; Mauceri Helena J
Radiation-induced tumour necrosis factor-alpha expression: clinical application of transcriptional and physical targeting of gene therapy.
The lancet oncology 2002;3(11):665-71.
-
2002: Advani S J; Weichselbaum R R; Whitley R J; Roizman B
Friendly fire: redirecting herpes simplex virus-1 for therapeutic applications.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2002;8(9):551-63.
-
2002: Park James O; Lopez Carlos A; Gupta Vinay K; Brown Charles K; Mauceri Helena J; Darga Thomas E; Manan Abdullah; Hellman Samuel; Posner Mitchell C; Kufe Donald W; Weichselbaum Ralph R
Transcriptional control of viral gene therapy by cisplatin.
The Journal of clinical investigation 2002;110(3):403-10.
-
2002: Gupta Vinay K; Park James O; Jaskowiak Nora T; Mauceri Helena J; Seetharam Saraswathy; Weichselbaum Ralph R; Posner Mitchell C
Combined gene therapy and ionizing radiation is a novel approach to treat human esophageal adenocarcinoma.
Annals of surgical oncology 2002;9(5):500-4.
-
2002: Kataoka Yasushi; Murley Jeffrey S; Khodarev Nikolai N; Weichselbaum Ralph R; Grdina David J
Activation of the nuclear transcription factor kappaB (NFkappaB) and differential gene expression in U87 glioma cells after exposure to the cytoprotector amifostine.
International journal of radiation oncology, biology, physics 2002;53(1):180-9.
-
2002: Khodarev N N; Yu J; Nodzenski E; Murley J S; Kataoka Y; Brown C K; Grdina D J; Weichselbaum R R
Method of RNA purification from endothelial cells for DNA array experiments.
BioTechniques 2002;32(2):316, 318, 320.
-
2002: Mauceri Helena J; Seetharam Saraswathy; Beckett Michael A; Lee John Y; Gupta Vinay K; Gately Stephen; Stack M Sharon; Brown Charles K; Swedberg Kirsten; Kufe Donald W; Weichselbaum Ralph R
Tumor production of angiostatin is enhanced after exposure to TNF-alpha.
International journal of cancer. Journal international du cancer 2002;97(4):410-5.
-
2002: Gupta Vinay K; Jaskowiak Nora T; Beckett Michael A; Mauceri Helena J; Grunstein Jeremy; Johnson Randall S; Calvin Douglas A; Nodzenski Edwardine; Pejovic Marija; Kufe Donald W; Posner Mitchell C; Weichselbaum Ralph R
Vascular endothelial growth factor enhances endothelial cell survival and tumor radioresistance.
Cancer journal (Sudbury, Mass.) 2002;8(1):47-54.
-
2002: Chung S-M; Advani S J; Bradley J D; Kataoka Y; Vashistha K; Yan S Y; Markert J M; Gillespie G Y; Whitley R J; Roizman B; Weichselbaum R R
The use of a genetically engineered herpes simplex virus (R7020) with ionizing radiation for experimental hepatoma.
Gene therapy 2002;9(1):75-80.
-
2002: Grdina David J; Kataoka Yasushi; Murley Jeffrey S; Hunter Nancy; Weichselbaum Ralph R; Milas Luka
Inhibition of spontaneous metastases formation by amifostine.
International journal of cancer. Journal international du cancer 2002;97(2):135-41.
-
2002: Abdalla I; Ignacio L; Vaida F; Mei-Hsu; Awan A; Jani A; Mamo C; Weichselbaum R R; Vijayakumar S
Evolution of toxicity after conformal radiotherapy for prostate cancer.
Prostate cancer and prostatic diseases 2002;5(4):296-303.
-
2001: Skelly C L; Curi M A; Meyerson S L; Woo D H; Hari D; Vosicky J E; Advani S J; Mauceri H J; Glagov S; Roizman B; Weichselbaum R R; Schwartz L B
Prevention of restenosis by a herpes simplex virus mutant capable of controlled long-term expression in vascular tissue in vivo.
Gene therapy 2001;8(24):1840-6.
-
2001: Jani A B; Vaida F; Hanks G; Asbell S; Sartor O; Moul J W; Roach M; Brachman D; Kalokhe U; Muller-Runkel R; Ray P; Ignacio L; Awan A; Weichselbaum R R; Vijayakumar S
Changing face and different countenances of prostate cancer: racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era.
International journal of cancer. Journal international du cancer 2001;96(6):363-71.
-
2001: Advani S J; Weichselbaum R R; Roizman B
cdc2 cyclin-dependent kinase binds and phosphorylates herpes simplex virus 1 U(L)42 DNA synthesis processivity factor.
Journal of virology 2001;75(21):10326-33.
-
2001: Chmura S J; Gupta N; Advani S J; Kufe D W; Weichselbaum R R
Prospects for viral-based strategies enhancing the anti-tumor effects of ionizing radiation.
Seminars in radiation oncology 2001;11(4):338-45.
-
2001: Khodarev N N; Park J O; Yu J; Gupta N; Nodzenski E; Roizman B; Weichselbaum R R
Dose-dependent and independent temporal patterns of gene responses to ionizing radiation in normal and tumor cells and tumor xenografts.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(22):12665-70.
-
2001: Gupta N; Wang H; McLeod T L; Naus C C; Kyurkchiev S; Advani S; Yu J; Perbal B; Weichselbaum R R
Inhibition of glioma cell growth and tumorigenic potential by CCN3 (NOV).
Molecular pathology : MP 2001;54(5):293-9.
-
2001: Mauceri H J; Seetharam S; Salloum R M; Vokes E E; Weichselbaum R R
Treatment of head and neck and esophageal xenografts employing Alimta and concurrent ionizing radiation.
International journal of oncology 2001;19(4):833-5.
-
2001: Advani S J; Hagglund R; Weichselbaum R R; Roizman B
Posttranslational processing of infected cell proteins 0 and 4 of herpes simplex virus 1 is sequential and reflects the subcellular compartment in which the proteins localize.
Journal of virology 2001;75(17):7904-12.
-
2001: Gupta N; Nodzenski E; Khodarev N N; Yu J; Khorasani L; Beckett M A; Kufe D W; Weichselbaum R R
Angiostatin effects on endothelial cells mediated by ceramide and RhoA.
EMBO reports 2001;2(6):536-40.
-
2001: Mantz C A; Vokes E E; Kies M S; Mittal B; Witt M E; List M A; Weichselbaum R R; Haraf D J
Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(3):343-7.
-
2001: Mantz C A; Vokes E E; Stenson K; Kies M S; Mittal B; Witt M E; List M A; Weichselbaum R R; Haraf D J
Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced oropharyngeal cancer.
Cancer journal (Sudbury, Mass.) 2001;7(2):140-8.
-
2001: Connell P P; Ignacio L; Haraf D; Awan A M; Halpern H; Abdalla I; Nautiyal J; Jani A B; Weichselbaum R R; Vijayakumar S
Equivalent racial outcome after conformal radiotherapy for prostate cancer: a single departmental experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(1):54-61.
-
2001: Weichselbaum R R; Kufe D W; Advani S J; Roizman B
Molecular targeting of gene therapy and radiotherapy.
Acta oncologica (Stockholm, Sweden) 2001;40(6):735-8.
-
2000: Salloum R M; Jaskowiak N T; Mauceri H J; Seetharam S; Beckett M A; Koons A M; Hari D M; Gupta V K; Reimer C; Kalluri R; Posner M C; Hellman S; Kufe D W; Weichselbaum R R
NM-3, an isocoumarin, increases the antitumor effects of radiotherapy without toxicity.
Cancer research 2000;60(24):6958-63.
-
2000: Pelizzari C A; Khodarev N N; Gupta N; Calvin D P; Weichselbaum R R
Quantitative analysis of DNA array autoradiographs.
Nucleic acids research 2000;28(22):4577-81.
-
2000: Hanna N N; Seetharam S; Mauceri H J; Beckett M A; Jaskowiak N T; Salloum R M; Hari D; Dhanabal M; Ramchandran R; Kalluri R; Sukhatme V P; Kufe D W; Weichselbaum R R
Antitumor interaction of short-course endostatin and ionizing radiation.
Cancer journal (Sudbury, Mass.) 2000;6(5):287-93.
-
2000: Advani S J; Weichselbaum R R; Roizman B
The role of cdc2 in the expression of herpes simplex virus genes.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(20):10996-1001.
-
2000: Advani S J; Weichselbaum R R; Roizman B
E2F proteins are posttranslationally modified concomitantly with a reduction in nuclear binding activity in cells infected with herpes simplex virus 1.
Journal of virology 2000;74(17):7842-50.
-
2000: Hannig J; Zhang D; Canaday D J; Beckett M A; Astumian R D; Weichselbaum R R; Lee R C
Surfactant sealing of membranes permeabilized by ionizing radiation.
Radiation research 2000;154(2):171-7.
-
2000: Stenson K M; Haraf D J; Pelzer H; Recant W; Kies M S; Weichselbaum R R; Vokes E E
The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective neck dissection.
Archives of otolaryngology--head & neck surgery 2000;126(8):950-6.
-
2000: Bhattacharyya A; Ear U S; Koller B H; Weichselbaum R R; Bishop D K
The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin.
The Journal of biological chemistry 2000;275(31):23899-903.
-
2000: Hari D; Beckett M A; Sukhatme V P; Dhanabal M; Nodzenski E; Lu H; Mauceri H J; Kufe D W; Weichselbaum R R
Angiostatin induces mitotic cell death of proliferating endothelial cells.
Molecular cell biology research communications : MCBRC 2000;3(5):277-82.
-
2000: Colorado P C; Torre A; Kamphaus G; Maeshima Y; Hopfer H; Takahashi K; Volk R; Zamborsky E D; Herman S; Sarkar P K; Ericksen M B; Dhanabal M; Simons M; Post M; Kufe D W; Weichselbaum R R; Sukhatme V P; Kalluri R
Anti-angiogenic cues from vascular basement membrane collagen.
Cancer research 2000;60(9):2520-6.
-
2000: Vokes E E; Kies M S; Haraf D J; Stenson K; List M; Humerickhouse R; Dolan M E; Pelzer H; Sulzen L; Witt M E; Hsieh Y C; Mittal B B; Weichselbaum R R
Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(8):1652-61.
-
2000: Fortunato J E; Mauceri H J; Kocharyan H; Song R H; Salloum R; Vosicky J; Swedberg K; Malik S; Abusharif F; Glagov S; Weichselbaum R R; Bassiouny H S
Gene therapy enhances the antiproliferative effect of radiation in intimal hyperplasia.
The Journal of surgical research 2000;89(2):155-62.
-
2000: Chmura S J; Nodzenski E; Kharbanda S; Pandey P; Quintans J; Kufe D W; Weichselbaum R R
Down-regulation of ceramide production abrogates ionizing radiation-induced cytochrome c release and apoptosis.
Molecular pharmacology 2000;57(4):792-6.
-
2000: Chmura S J; Dolan M E; Cha A; Mauceri H J; Kufe D W; Weichselbaum R R
In vitro and in vivo activity of protein kinase C inhibitor chelerythrine chloride induces tumor cell toxicity and growth delay in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(2):737-42.
-
2000: Advani S J; Brandimarti R; Weichselbaum R R; Roizman B
The disappearance of cyclins A and B and the increase in activity of the G(2)/M-phase cellular kinase cdc2 in herpes simplex virus 1-infected cells require expression of the alpha22/U(S)1.5 and U(L)13 viral genes.
Journal of virology 2000;74(1):8-15.
-
1999: Connell P P; Ignacio L; McBride R B; Weichselbaum R R; Vijayakumar S
Caution in interpreting biochemical control rates after treatment of prostate cancer: length of follow-up influences results.
Urology 1999;54(5):875-9.
-
1999: Terry M A; Hannig J; Carrillo C S; Beckett M A; Weichselbaum R R; Lee R C
Oxidative cell membrane alteration. Evidence for surfactant-mediated sealing.
Annals of the New York Academy of Sciences 1999;888():274-84.
-
1999: Khodarev N N; Advani S J; Gupta N; Roizman B; Weichselbaum R R
Accumulation of specific RNAs encoding transcriptional factors and stress response proteins against a background of severe depletion of cellular RNAs in cells infected with herpes simplex virus 1.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(21):12062-7.
-
1999: Jani A B; Chen M H; Vaida F; Ignacio L; Awan A; Weichselbaum R R; Vijayakumar S
PSA-based outcome analysis after radiation therapy for prostate cancer: a new definition of biochemical failure after intervention.
Urology 1999;54(4):700-5.
-
1999: Seetharam S; Staba M J; Schumm L P; Schreiber K; Schreiber H; Kufe D W; Weichselbaum R R
Enhanced eradication of local and distant tumors by genetically produced interleukin-12 and radiation.
International journal of oncology 1999;15(4):769-73.
-
1999: Lee M M; Vokes E E; Rosen A; Witt M E; Weichselbaum R R; Haraf D J
Multimodality therapy in advanced paranasal sinus carcinoma: superior long-term results.
The cancer journal from Scientific American 1999;5(4):219-23.
-
1999: Gorski D H; Beckett M A; Jaskowiak N T; Calvin D P; Mauceri H J; Salloum R M; Seetharam S; Koons A; Hari D M; Kufe D W; Weichselbaum R R
Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.
Cancer research 1999;59(14):3374-8.
-
1999: Bradley J D; Kataoka Y; Advani S; Chung S M; Arani R B; Gillespie G Y; Whitley R J; Markert J M; Roizman B; Weichselbaum R R
Ionizing radiation improves survival in mice bearing intracranial high-grade gliomas injected with genetically modified herpes simplex virus.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(6):1517-22.
-
1999: Lee J S; Jani A B; Pelizzari C A; Haraf D J; Vokes E E; Weichselbaum R R; Chen G T
Volumetric visualization of head and neck CT data for treatment planning.
International journal of radiation oncology, biology, physics 1999;44(3):693-703.
-
1999: Advani S J; Chung S M; Yan S Y; Gillespie G Y; Markert J M; Whitley R J; Roizman B; Weichselbaum R R
Replication-competent, nonneuroinvasive genetically engineered herpes virus is highly effective in the treatment of therapy-resistant experimental human tumors.
Cancer research 1999;59(9):2055-8.
-
1999: Vokes E E; Haraf D J; Brockstein B E; Weichselbaum R R
Paclitaxel, 5-fluorouracil, hydroxyurea, and concomitant radiation therapy for poor-prognosis head and neck cancer.
Seminars in radiation oncology 1999;9(2 Suppl 1):70-6.
-
1999: Mauceri H J; Hanna N N; Staba M J; Beckett M A; Kufe D W; Weichselbaum R R
Radiation-inducible gene therapy.
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1999;322(2-3):225-8.
-
1999: Haraf D J; Kies M; Rademaker A W; Stenson K; Mittal B; Pelzer H; Wenig B; Witt M E; Sulzen L; Weichselbaum R R; Vokes E E
Radiation therapy with concomitant hydroxyurea and fluorouracil in stage II and III head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(2):638-44.
-
1999: Chmura S J; Advani S J; Kufe D W; Weichselbaum R R
Strategies for enhancing viral-based gene therapy using ionizing radiation.
Radiation oncology investigations 1999;7(5):261-9.
-
1998: Gorski D H; Mauceri H J; Salloum R M; Gately S; Hellman S; Beckett M A; Sukhatme V P; Soff G A; Kufe D W; Weichselbaum R R
Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin.
Cancer research 1998;58(24):5686-9.
-
1998: Chung T D; Mauceri H J; Hallahan D E; Yu J J; Chung S; Grdina W L; Yajnik S; Kufe D W; Weichselbaum R R
Tumor necrosis factor-alpha-based gene therapy enhances radiation cytotoxicity in human prostate cancer.
Cancer gene therapy 1998;5(6):344-9.
-
1998: Bishop D K; Ear U; Bhattacharyya A; Calderone C; Beckett M; Weichselbaum R R; Shinohara A
Xrcc3 is required for assembly of Rad51 complexes in vivo.
The Journal of biological chemistry 1998;273(34):21482-8.
-
1998: Kies M S; Haraf D J; Athanasiadis I; Kozloff M; Mittal B; Pelzer H; Rademaker A W; Wenig B; Weichselbaum R R; Vokes E E
Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(8):2715-21.
-
1998: Seetharam S; Nodzenski E; Beckett M A; Heimann R; Cha A; Margulies I; Pastan I; Kufe D W; Weichselbaum R R
Modulation of apoptotic response of a radiation-resistant human carcinoma by Pseudomonas exotoxin-chimeric protein.
Cancer research 1998;58(15):3215-20.
-
1998: Mauceri H J; Hanna N N; Beckett M A; Gorski D H; Staba M J; Stellato K A; Bigelow K; Heimann R; Gately S; Dhanabal M; Soff G A; Sukhatme V P; Kufe D W; Weichselbaum R R
Combined effects of angiostatin and ionizing radiation in antitumour therapy.
Nature 1998;394(6690):287-91.
-
1998: Staba M J; Mauceri H J; Kufe D W; Hallahan D E; Weichselbaum R R
Adenoviral TNF-alpha gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft.
Gene therapy 1998;5(3):293-300.
-
1998: Advani S J; Sibley G S; Song P Y; Hallahan D E; Kataoka Y; Roizman B; Weichselbaum R R
Enhancement of replication of genetically engineered herpes simplex viruses by ionizing radiation: a new paradigm for destruction of therapeutically intractable tumors.
Gene therapy 1998;5(2):160-5.
-
1998: Brockstein B; Haraf D J; Stenson K; Fasanmade A; Stupp R; Glisson B; Lippman S M; Ratain M J; Sulzen L; Klepsch A; Weichselbaum R R; Vokes E E
Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(2):735-44.
-
1997: Advani S J; Chmura S J; Weichselbaum R R
Radiogenetic therapy: on the interaction of viral therapy and ionizing radiation for improving local control of tumors.
Seminars in oncology 1997;24(6):633-8.
-
1997: Portugal L G; Goldenberg J D; Wenig B L; Ferrer K T; Nodzenski E; Sabnani J B; Javier C; Weichselbaum R R; Vokes E E
Human papillomavirus expression and p53 gene mutations in squamous cell carcinoma.
Archives of otolaryngology--head & neck surgery 1997;123(11):1230-4.
-
1997: Chmura S J; Mauceri H J; Advani S; Heimann R; Beckett M A; Nodzenski E; Quintans J; Kufe D W; Weichselbaum R R
Decreasing the apoptotic threshold of tumor cells through protein kinase C inhibition and sphingomyelinase activation increases tumor killing by ionizing radiation.
Cancer research 1997;57(19):4340-7.
-
1997: Hanna N N; Mauceri H J; Wayne J D; Hallahan D E; Kufe D W; Weichselbaum R R
Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts.
Cancer research 1997;57(19):4205-9.
-
1997: Heimann R; Ferguson D; Powers C; Suri D; Weichselbaum R R; Hellman S
Race and clinical outcome in breast cancer in a series with long-term follow-up evaluation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(6):2329-37.
-
1997: Chmura S J; Nodzenski E; Beckett M A; Kufe D W; Quintans J; Weichselbaum R R
Loss of ceramide production confers resistance to radiation-induced apoptosis.
Cancer research 1997;57(7):1270-5.
-
1997: Johnston P G; Mick R; Recant W; Behan K A; Dolan M E; Ratain M J; Beckmann E; Weichselbaum R R; Allegra C J; Vokes E E
Thymidylate synthase expression and response to neoadjuvant chemotherapy in patients with advanced head and neck cancer.
Journal of the National Cancer Institute 1997;89(4):308-13.
-
1997: Haraf D J; Stenson K; List M; Witt M E; Weichselbaum R R; Vokes E E
Continuous infusion paclitaxel, 5-fluorouracil, and hydroxyurea with concomitant radiotherapy in patients with advanced or recurrent head and neck cancer.
Seminars in oncology 1997;24(1 Suppl 2):S2-68-S2-71.
-
1997: Roeske J C; Mundt A J; Halpern H; Sweeney P; Sutton H; Powers C; Rotmensch J; Waggoner S; Weichselbaum R R
Late rectal sequelae following definitive radiation therapy for carcinoma of the uterine cervix: a dosimetric analysis.
International journal of radiation oncology, biology, physics 1997;37(2):351-8.
-
1997: Hamilton R J; Sweeney P J; Pelizzari C A; Yetkin F Z; Holman B L; Garada B; Weichselbaum R R; Chen G T
Functional imaging in treatment planning of brain lesions.
International journal of radiation oncology, biology, physics 1997;37(1):181-8.
-
1997: Mauceri H J; Seung L P; Grdina W L; Swedberg K A; Weichselbaum R R
Increased injection number enhances adenoviral genetic radiotherapy.
Radiation oncology investigations 1997;5(5):220-6.
-
1996: Seung L P; Weichselbaum R R; Toledano A; Schreiber K; Schreiber H
Radiation can inhibit tumor growth indirectly while depleting circulating leukocytes.
Radiation research 1996;146(6):612-8.
-
1996: Quiet C A; Ferguson D J; Weichselbaum R R; Hellman S
Natural history of node-positive breast cancer: the curability of small cancers with a limited number of positive nodes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(12):3105-11.
-
1996: Heimann R; Ferguson D; Powers C; Recant W M; Weichselbaum R R; Hellman S
Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer.
Journal of the National Cancer Institute 1996;88(23):1764-9.
-
1996: Haraf D J; Weichselbaum R R; Vokes E E
Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(9):913-8.
-
1996: Heimann R; Powers C; Halpem H J; Michel A G; Ewing C A; Wyman B; Recant W; Weichselbaum R R
Breast preservation in stage I and II carcinoma of the breast. The University of Chicago experience.
Cancer 1996;78(8):1722-30.
-
1996: Mauceri H J; Hanna N N; Wayne J D; Hallahan D E; Hellman S; Weichselbaum R R
Tumor necrosis factor alpha (TNF-alpha) gene therapy targeted by ionizing radiation selectively damages tumor vasculature.
Cancer research 1996;56(19):4311-4.
-
1996: Hallahan D E; Dunphy E; Kuchibhotla J; Kraft A; Unlap T; Weichselbaum R R
Prolonged c-jun expression in irradiated ataxia telangiectasia fibroblasts.
International journal of radiation oncology, biology, physics 1996;36(2):355-60.
-
1996: Chmura S J; Nodzenski E; Weichselbaum R R; Quintans J
Protein kinase C inhibition induces apoptosis and ceramide production through activation of a neutral sphingomyelinase.
Cancer research 1996;56(12):2711-4.
-
1996: Hellman S; Weichselbaum R R
Radiation oncology.
JAMA : the journal of the American Medical Association 1996;275(23):1852-3.
-
1996: Vokes E E; Mick R; Kies M S; Dolan M E; Malone D; Athanasiadis I; Haraf D J; Kozloff M; Weichselbaum R R; Ratain M J
Pharmacodynamics of fluorouracil-based induction chemotherapy in advanced head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(5):1663-71.
-
1996: Haraf D J; Nodzenski E; Brachman D; Mick R; Montag A; Graves D; Vokes E E; Weichselbaum R R
Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(4):755-62.
-
1996: Chmura S J; Nodzenski E; Crane M A; Virudachalam S; Hallahan D E; Weichselbaum R R; Quintans J
Cross-talk between ceramide and PKC activity in the control of apoptosis in WEHI-231.
Advances in experimental medicine and biology 1996;406():39-55.
-
1995: Hallahan D E; Dunphy E; Virudachalam S; Sukhatme V P; Kufe D W; Weichselbaum R R
C-jun and Egr-1 participate in DNA synthesis and cell survival in response to ionizing radiation exposure.
The Journal of biological chemistry 1995;270(51):30303-9.
-
1995: Seung L P; Mauceri H J; Beckett M A; Hallahan D E; Hellman S; Weichselbaum R R
Genetic radiotherapy overcomes tumor resistance to cytotoxic agents.
Cancer research 1995;55(23):5561-5.
-
1995: Vokes E E; Haraf D J; Stenson K; Stupp R; Malone D; Levin J; Weichselbaum R R
The role of paclitaxel in the treatment of head and neck cancer.
Seminars in oncology 1995;22(5 Suppl 12):8-12.
-
1995: Hallahan D E; Vokes E E; Rubin S J; O'Brien S; Samuels B; Vijaykumar S; Kufe D W; Phillips R; Weichselbaum R R
Phase I dose-escalation study of tumor necrosis factor-alpha and concomitant radiation therapy.
The cancer journal from Scientific American 1995;1(3):204-9.
-
1995: Hellman S; Weichselbaum R R
Radiation oncology and the new biology.
The cancer journal from Scientific American 1995;1(3):174-9.
-
1995: Mundt A J; Sibley G; Williams S; Hallahan D; Nautiyal J; Weichselbaum R R
Patterns of failure following high-dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease.
International journal of radiation oncology, biology, physics 1995;33(2):261-70.
-
1995: Haraf D J; Rubin S J; Sweeney P; Kuchnir F T; Sutton H G; Chodak G W; Weichselbaum R R
Photon neutron mixed-beam radiotherapy of locally advanced prostate cancer.
International journal of radiation oncology, biology, physics 1995;33(1):3-14.
-
1995: Hallahan D E; Mauceri H J; Seung L P; Dunphy E J; Wayne J D; Hanna N N; Toledano A; Hellman S; Kufe D W; Weichselbaum R R
Spatial and temporal control of gene therapy using ionizing radiation.
Nature medicine 1995;1(8):786-91.
-
1995: Mundt A J; Awan A; Sibley G S; Simon M; Rubin S J; Samuels B; Wong W; Beckett M; Vijayakumar S; Weichselbaum R R
Conservative surgery and adjuvant radiation therapy in the management of adult soft tissue sarcoma of the extremities: clinical and radiobiological results.
International journal of radiation oncology, biology, physics 1995;32(4):977-85.
-
1995: Sibley G S; Mundt A J; Goldman S; Nachman J; Reft C; Weichselbaum R R; Hallahan D E; Johnson L
Patterns of failure following total body irradiation and bone marrow transplantation with or without a radiotherapy boost for advanced neuroblastoma.
International journal of radiation oncology, biology, physics 1995;32(4):1127-35.
-
1995: Vokes E E; Stupp R; Haraf D; Moran W; Malone D; Wenig B; Sweeney P; Weichselbaum R R
Hydroxyurea with continuous infusion paclitaxel, 5-fluorouracil, and concomitant radiotherapy for poor-prognosis head and neck cancer.
Seminars in oncology 1995;22(3 Suppl 6):47-52.
-
1995: Weichselbaum R R
Growth factors alter the therapeutic ratio in radiotherapy.
The cancer journal from Scientific American 1995;1(1):28-9.
-
1995: Quiet C A; Ferguson D J; Weichselbaum R R; Hellman S
Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(5):1144-51.
-
1995: Vijayakumar S; Quadri S F; Sen S; Vaida F; Ignacio L; Weichselbaum R R
Measurement of weekly prostate specific antigen levels in patients receiving pelvic radiotherapy for nonprostatic malignancies.
International journal of radiation oncology, biology, physics 1995;32(1):189-95.
-
1995: Chen M; Quintans J; Fuks Z; Thompson C; Kufe D W; Weichselbaum R R
Suppression of Bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factor alpha, and ceramide.
Cancer research 1995;55(5):991-4.
-
1995: Haraf D J; Weichselbaum R R; Vokes E E
Timing and sequencing of chemoradiotherapy.
Cancer treatment and research 1995;74():173-98.
-
1995: Weichselbaum R R; Beckett M A; Vokes E E; Brachman D G; Haraf D; Hallahan D; Kufe D
Cellular and molecular mechanisms of radioresistance.
Cancer treatment and research 1995;74():131-40.
-
1995: Krishnasamy S; Vokes E E; Dohrmann G J; Mick R; Garcia J C; Kolker J D; Wollmann R L; Hekmatpanah J; Weichselbaum R R
Concomitant chemoradiotherapy, neutron boost, and adjuvant chemotherapy for anaplastic astrocytoma and glioblastoma multiforme.
Cancer investigation 1995;13(5):453-9.
-
1994: Vokes E E; Haraf D J; Mick R; McEvilly J M; Weichselbaum R R
Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(11):2351-9.
-
1994: Weichselbaum R R; Hallahan D; Fuks Z; Kufe D
Radiation induction of immediate early genes: effectors of the radiation-stress response.
International journal of radiation oncology, biology, physics 1994;30(1):229-34.
-
1994: Mundt A J; Sibley G S; Williams S; Rubin S J; Heimann R; Halpern H; Weichselbaum R R
Patterns of failure of complete responders following high-dose chemotherapy and autologous bone marrow transplantation for metastatic breast cancer: implications for the use of adjuvant radiation therapy.
International journal of radiation oncology, biology, physics 1994;30(1):151-60.
-
1994: Weichselbaum R R; Hallahan D E; Beckett M A; Mauceri H J; Lee H; Sukhatme V P; Kufe D W
Gene therapy targeted by radiation preferentially radiosensitizes tumor cells.
Cancer research 1994;54(16):4266-9.
-
1994: Hallahan D E; Virudachalam S; Kufe D W; Weichselbaum R R
Ketoconazole attenuates radiation-induction of tumor necrosis factor.
International journal of radiation oncology, biology, physics 1994;29(4):777-80.
-
1994: Stupp R; Weichselbaum R R; Vokes E E
Combined modality therapy of head and neck cancer.
Seminars in oncology 1994;21(3):349-58.
-
1994: Sweeney P J; Haraf D J; Vokes E E; Dougherty M; Weichselbaum R R
Radiation therapy in head and neck cancer: indications and limitations.
Seminars in oncology 1994;21(3):296-303.
-
1994: Hallahan D E; Bleakman D; Virudachalam S; Lee D; Grdina D; Kufe D W; Weichselbaum R R
The role of intracellular calcium in the cellular response to ionizing radiation.
Radiation research 1994;138(3):392-400.
-
1994: Hellman S; Weichselbaum R R
Radiation oncology.
JAMA : the journal of the American Medical Association 1994;271(21):1712-4.
-
1994: Hallahan D E; Virudachalam S; Kuchibhotla J; Kufe D W; Weichselbaum R R
Membrane-derived second messenger regulates x-ray-mediated tumor necrosis factor alpha gene induction.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(11):4897-901.
-
1994: Wong W W; Mick R; Haraf D J; Weichselbaum R R; Vokes E E
Time-dose relationship for local tumor control following alternate week concomitant radiation and chemotherapy of advanced head and neck cancer.
International journal of radiation oncology, biology, physics 1994;29(1):153-62.
-
1993: Cowan J M; Beckett M A; Weichselbaum R R
Chromosome changes characterizing in vitro response to radiation in human squamous cell carcinoma lines.
Cancer research 1993;53(22):5542-7.
-
1993: Brachman D G; Beckett M; Graves D; Haraf D; Vokes E; Weichselbaum R R
p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines.
Cancer research 1993;53(16):3667-9.
-
1993: Rosen A; Vokes E E; Scher N; Haraf D; Weichselbaum R R; Panje W R
Locoregionally advanced paranasal sinus carcinoma. Favorable survival with multimodality therapy.
Archives of otolaryngology--head & neck surgery 1993;119(7):743-6.
-
1993: Pekarek L A; Weichselbaum R R; Beckett M A; Nachman J; Schreiber H
Footprinting of individual tumors and their variants by constitutive cytokine expression patterns.
Cancer research 1993;53(9):1978-81.
-
1993: Vogelzang N J; Moormeier J A; Awan A M; Weichselbaum R R; Farah R; Straus F H; Schoenberg H W; Chodak G W
Methotrexate, vinblastine, doxorubicin and cisplatin followed by radiotherapy or surgery for muscle invasive bladder cancer: the University of Chicago experience.
The Journal of urology 1993;149(4):753-7.
-
1993: Hallahan D E; Gius D; Kuchibhotla J; Sukhatme V; Kufe D W; Weichselbaum R R
Radiation signaling mediated by Jun activation following dissociation from a cell type-specific repressor.
The Journal of biological chemistry 1993;268(7):4903-7.
-
1993: Vokes E E; Ratain M J; Mick R; McEvilly J M; Haraf D; Kozloff M; Hamasaki V; Weichselbaum R R; Panje W R; Wenig B
Cisplatin, fluorouracil, and leucovorin augmented by interferon alfa-2b in head and neck cancer: a clinical and pharmacologic analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(2):360-8.
-
1992: Vijayakumar S; Karrison T; Weichselbaum R R; Chan S; Quadri S F; Awan A M
Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1992;1(7):541-5.
-
1992: Brachman D G; Graves D; Vokes E; Beckett M; Haraf D; Montag A; Dunphy E; Mick R; Yandell D; Weichselbaum R R
Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer.
Cancer research 1992;52(17):4832-6.
-
1992: Vokes E E; Haraf D J; Weichselbaum R R; McEvilly J M; Sutton H G; Panje W R
Perspectives on combination chemotherapy with concomitant radiotherapy for poor-prognosis head and neck cancer.
Seminars in oncology 1992;19(4 Suppl 11):47-56.
-
1992: Weichselbaum R R; Beckett M A; Hallahan D E; Kufe D W; Vokes E E
Molecular targets to overcome radioresistance.
Seminars in oncology 1992;19(4 Suppl 11):14-20.
-
1992: Vokes E E; Haraf D J; Panje W R; Schilsky R L; Weichselbaum R R
Hydroxyurea with concomitant radiotherapy for locally advanced head and neck cancer.
Seminars in oncology 1992;19(3 Suppl 9):53-8.
-
1992: Haraf D J; Vokes E E; Weichselbaum R R; Panje W R
Concomitant chemoradiotherapy with cisplatin, 5-fluorouracil and hydroxyurea in poor-prognosis head and neck cancer.
The Laryngoscope 1992;102(6):630-6.
-
1992: Vokes E E; Weichselbaum R R; Mick R; McEvilly J M; Haraf D J; Panje W R
Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer.
Journal of the National Cancer Institute 1992;84(11):877-82.
-
1992: Wong W W; Vijayakumar S; Weichselbaum R R
Prognostic indicators in node-negative early stage breast cancer.
The American journal of medicine 1992;92(5):539-48.
-
1992: Dunphy E J; Beckett M A; Thompson L H; Weichselbaum R R
Expression of the polymorphic human DNA repair gene XRCC1 does not correlate with radiosensitivity in the cells of human head and neck tumor cell lines.
Radiation research 1992;130(2):166-70.
-
1992: Cowan J M; Beckett M A; Ahmed-Swan S; Weichselbaum R R
Cytogenetic evidence of the multistep origin of head and neck squamous cell carcinomas.
Journal of the National Cancer Institute 1992;84(10):793-7.
-
1992: Hallahan D E; Virudachalam S; Schwartz J L; Panje N; Mustafi R; Weichselbaum R R
Inhibition of protein kinases sensitizes human tumor cells to ionizing radiation.
Radiation research 1992;129(3):345-50.
-
1992: Platanias L C; Putterman A M; Vijayakumar S; Recant W; Weichselbaum R R; Bitran J D
Treatment and prognosis of orbital non-Hodgkin's lymphomas.
American journal of clinical oncology 1992;15(1):79-83.
-
1992: Vokes E E; Haraf D J; McEvilly J M; Mick R; Kozloff M F; Goldman M D; Moran W J; Clendeninn N J; Collier M A; Weichselbaum R R
Neoadjuvant PFL augmented by methotrexate and piritrexim followed by concomitant chemoradiotherapy for advanced head and neck cancer: a feasible and active approach.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(1):79-81.
-
1992: Vokes E E; Moormeier J A; Ratain M J; Egorin M J; Haraf D J; Mick R; Weichselbaum R R
5-Fluorouracil, leucovorin, hydroxyurea, and escalating doses of continuous-infusion cisplatin with concomitant radiotherapy: a clinical and pharmacologic study.
Cancer chemotherapy and pharmacology 1992;29(3):178-84.
-
1992: Jaffe D R; Montero-Puerner Y; Beckett M A; Cowan J M; Weichselbaum R R; Diamond A M
Differential retention of tumor- and differentiation-suppressor functions in cells derived from a human squamous cell carcinoma.
Molecular carcinogenesis 1992;5(4):278-85.
-
1992: Vokes E E; Beckett M; Karrison T; Weichselbaum R R
The interaction of 5-fluorouracil, hydroxyurea, and radiation in two human head and neck cancer cell lines.
Oncology 1992;49(6):454-60.
-
1992: Hallahan D E; Virudachalam S; Grdina D; Weichselbaum R R
The isoquinoline sulfonamide H7 attenuates radiation-mediated protein kinase C activation and delays the onset of x-ray-induced G2 arrest.
International journal of radiation oncology, biology, physics 1992;24(4):687-92.
-
1992: Weichselbaum R R; Hallahan D E; Sukhatme V P; Kufe D W
Gene therapy targeted by ionizing radiation.
International journal of radiation oncology, biology, physics 1992;24(3):565-7.
-
1991: Brachman D G; Hallahan D E; Beckett M A; Yandell D W; Weichselbaum R R
p53 gene mutations and abnormal retinoblastoma protein in radiation-induced human sarcomas.
Cancer research 1991;51(23 Pt 1):6393-6.
-
1991: Hallahan D E; Virudachalam S; Beckett M; Sherman M L; Kufe D; Weichselbaum R R
Mechanisms of X-ray-mediated protooncogene c-jun expression in radiation-induced human sarcoma cell lines.
International journal of radiation oncology, biology, physics 1991;21(6):1677-81.
-
1991: Haraf D J; Vokes E E; Panje W R; Weichselbaum R R
Survival and analysis of failure following hydroxyurea, 5-fluorouracil and concomitant radiation therapy in poor prognosis head and neck cancer.
American journal of clinical oncology 1991;14(5):419-26.
-
1991: Hallahan D E; Virudachalam S; Sherman M L; Huberman E; Kufe D W; Weichselbaum R R
Tumor necrosis factor gene expression is mediated by protein kinase C following activation by ionizing radiation.
Cancer research 1991;51(17):4565-9.
-
1991: Vokes E E; Mick R; Lester E P; Panje W R; Weichselbaum R R
Cisplatin and fluorouracil chemotherapy does not yield long-term benefit in locally advanced head and neck cancer: results from a single institution.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(8):1376-84.
-
1991: Vokes E E; Awan A M; Weichselbaum R R
Radiotherapy with concomitant chemotherapy for head and neck cancer.
Hematology/oncology clinics of North America 1991;5(4):753-67.
-
1991: Awan A M; Vokes E E; Weichselbaum R R
Recent advances in radiation therapy for head and neck cancer.
Hematology/oncology clinics of North America 1991;5(4):635-55.
-
1991: Haraf D J; Drucker D R; Weichselbaum R R; Diamond A M
Radioresistant derivatives of radiosensitive CHO cells obtained following treatment with 5-azacytidine retain their sensitivity to cisplatin.
Radiation research 1991;127(2):226-9.
-
1991: Mick R; Vokes E E; Weichselbaum R R; Panje W R
Prognostic factors in advanced head and neck cancer patients undergoing multimodality therapy.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 1991;105(1):62-73.
-
1991: Halpern H J; Jaffe D R; Nguyen T D; Haraf D J; Spencer D P; Bowman M K; Weichselbaum R R; Diamond A M
Measurement of bioreduction rates of cells with distinct responses to ionizing radiation and cisplatin.
Biochimica et biophysica acta 1991;1093(2-3):121-4.
-
1991: Schwartz J L; Mustafi R; Beckett M A; Czyzewski E A; Farhangi E; Grdina D J; Rotmensch J; Weichselbaum R R
Radiation-induced DNA double-strand break frequencies in human squamous cell carcinoma cell lines of different radiation sensitivities.
International journal of radiation biology 1991;59(6):1341-52.
-
1991: Weichselbaum R R; Hallahan D E; Sukhatme V; Dritschilo A; Sherman M L; Kufe D W
Biological consequences of gene regulation after ionizing radiation exposure.
Journal of the National Cancer Institute 1991;83(7):480-4.
-
1991: Quiet C A; Weichselbaum R R; Grdina D J
Variation in radiation sensitivity during the cell cycle of two human squamous cell carcinomas.
International journal of radiation oncology, biology, physics 1991;20(4):733-8.
-
1991: Springate S C; Haraf D; Weichselbaum R R
Temporal bone chemodectomas--comparing surgery and radiation therapy.
Oncology (Williston Park, N.Y.) 1991;5(4):131-7; discussion 140, 143.
-
1991: Farah R; Chodak G W; Vogelzang N J; Awan A M; Quiet C A; Moormeier J; Schoenberg H; Weichselbaum R R
Curative radiotherapy following chemotherapy for invasive bladder carcinoma (a preliminary report).
International journal of radiation oncology, biology, physics 1991;20(3):413-7.
-
1991: Hallahan D E; Sukhatme V P; Sherman M L; Virudachalam S; Kufe D; Weichselbaum R R
Protein kinase C mediates x-ray inducibility of nuclear signal transducers EGR1 and JUN.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(6):2156-60.
-
1991: Rubin S J; Hallahan D E; Ashman C R; Brachman D G; Beckett M A; Virudachalam S; Yandell D W; Weichselbaum R R
Two prostate carcinoma cell lines demonstrate abnormalities in tumor suppressor genes.
Journal of surgical oncology 1991;46(1):31-6.
-
1991: Samuels B L; Murray J L; Cohen M B; Safa A R; Sinha B K; Townsend A J; Beckett M A; Weichselbaum R R
Increased glutathione peroxidase activity in a human sarcoma cell line with inherent doxorubicin resistance.
Cancer research 1991;51(2):521-7.
-
1990: Roeske J C; Chen G T; Atcher R W; Pelizzari C A; Rotmensch J; Haraf D; Montag A; Weichselbaum R R
Modeling of dose to tumor and normal tissue from intraperitoneal radioimmunotherapy with alpha and beta emitters.
International journal of radiation oncology, biology, physics 1990;19(6):1539-48.
-
1990: Awan A M; Weichselbaum R R
Palliative radiotherapy.
Hematology/oncology clinics of North America 1990;4(6):1169-81.
-
1990: Cowan J M; Beckett M A; Tarbell N; Weichselbaum R R
Symmetrical chromosome rearrangements in cell lines established from human radiation-induced sarcomas.
Cancer genetics and cytogenetics 1990;50(1):125-37.
-
1990: Cowan J M; Beckett M A; Tarbell N J; Weichselbaum R R
Monosomy 12p in a radiation-induced germ cell tumor.
Genes, chromosomes & cancer 1990;2(3):186-90.
-
1990: Weichselbaum R R; Beckett M A; Vijayakumar S; Simon M A; Awan A M; Nachman J; Panje W R; Goldman M E; Tybor A G; Moran W J
Radiobiological characterization of head and neck and sarcoma cells derived from patients prior to radiotherapy.
International journal of radiation oncology, biology, physics 1990;19(2):313-9.
-
1990: Jaffe D R; Haraf D; Schwartz J L; Weichselbaum R R; Diamond A M
Radioresistant derivatives of an X-ray-sensitive CHO cell line exhibit distinct patterns of sensitivity to DNA-damaging agents.
Carcinogenesis 1990;11(8):1265-9.
-
1990: Hallahan D E; Beckett M A; Kufe D; Weichselbaum R R
The interaction between recombinant human tumor necrosis factor and radiation in 13 human tumor cell lines.
International journal of radiation oncology, biology, physics 1990;19(1):69-74.
-
1990: Schwartz J L; Mustafi R; Beckett M A; Weichselbaum R R
Prediction of the radiation sensitivity of human squamous cell carcinoma cells using DNA filter elution.
Radiation research 1990;123(1):1-6.
-
1990: Rader J S; Haraf D J; Halpern H J; Rotmensch J; Spelbring D R; Sutton H; Javaheri G; Weichselbaum R R
Radiation therapy in the treatment of cervical cancer: the University of Chicago/Michael Reese Hospital experience.
Journal of surgical oncology 1990;44(3):157-65.
-
1990: Vokes E E; Panje W R; Mick R; Kozloff M F; Moran W J; Sutton H G; Goldman M D; Tybor A G; Weichselbaum R R
A randomized study comparing two regimens of neoadjuvant and adjuvant chemotherapy in multimodal therapy for locally advanced head and neck cancer.
Cancer 1990;66(2):206-13.
-
1990: Springate S C; Weichselbaum R R
Radiation or surgery for chemodectoma of the temporal bone: a review of local control and complications.
Head & neck 1990;12(4):303-7.
-
1990: Vokes E E; Weichselbaum R R
Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(5):911-34.
-
1990: Rotmensch J; Rubin S J; Sutton H G; Javaheri G; Halpern H J; Schwartz J L; Stewart M; Weichselbaum R R; Herbst A L
Preoperative radiotherapy followed by radical vulvectomy with inguinal lymphadenectomy for advanced vulvar carcinomas.
Gynecologic oncology 1990;36(2):181-4.
-
1990: Vokes E E; Schilsky R L; Weichselbaum R R; Kozloff M F; Panje W R
Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for locally advanced head and neck cancer: a clinical and pharmacologic analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(2):241-7.
-
1989: Hallahan D E; Spriggs D R; Beckett M A; Kufe D W; Weichselbaum R R
Increased tumor necrosis factor alpha mRNA after cellular exposure to ionizing radiation.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(24):10104-7.
-
1989: Hallahan D E; Michel A G; Halpern H J; Awan A M; Desser R; Bitran J; Recant W; Wyman B; Spelbring D R; Weichselbaum R R
Breast conserving surgery and definitive irradiation for early stage breast cancer.
International journal of radiation oncology, biology, physics 1989;17(6):1211-6.
-
1989: Weichselbaum R R; Rotmensch J; Ahmed-Swan S; Beckett M A
Radiobiological characterization of 53 human tumor cell lines.
International journal of radiation biology 1989;56(5):553-60.
-
1989: Farah R; Golomb H M; Hallahan D E; Desser R K; Griem M L; Blough R; Ultmann J E; Weichselbaum R R
Radiation therapy for pathologic stage III Hodgkin's disease with and without chemotherapy.
International journal of radiation oncology, biology, physics 1989;17(4):761-6.
-
1989: Hallahan D E; Farah R; Vokes E E; Bitran J D; Ultmann J E; Golomb H M; Weichselbaum R R
The patterns of failure in patients with pathological stage I and II diffuse histiocytic lymphoma treated with radiation therapy alone.
International journal of radiation oncology, biology, physics 1989;17(4):767-71.
-
1989: Weichselbaum R R; Dunphy E J; Beckett M A; Tybor A G; Moran W J; Goldman M E; Vokes E E; Panje W R
Epidermal growth factor receptor gene amplification and expression in head and neck cancer cell lines.
Head & neck 1989;11(5):437-42.
-
1989: Weichselbaum R R; Beckett M A; Vijayakumar S; Ahmed-Swan S; Dritschilo A; Schwartz J L; Moran W J; Goldman M E; Tybor A G; Vokes E E
Radioresistant tumor cell lines derived from head and neck radiation failures.
Head & neck 1989;11(4):343-8.
-
1989: Vokes E E; Moran W J; Mick R; Weichselbaum R R; Panje W R
Neoadjuvant and adjuvant methotrexate, cisplatin, and fluorouracil in multimodal therapy of head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(7):838-45.
-
1989: Vokes E E; Bitran J D; Hoffman P C; Ferguson M K; Weichselbaum R R; Golomb H M
Neoadjuvant vindesine, etoposide, and cisplatin for locally advanced non-small cell lung cancer. Final report of a phase 2 study.
Chest 1989;96(1):110-3.
-
1989: Vokes E E; Panje W R; Schilsky R L; Mick R; Awan A M; Moran W J; Goldman M D; Tybor A G; Weichselbaum R R
Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I-II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(6):761-8.
-
1989: Farah R; Weichselbaum R R
Substaging of stage III Hodgkin's disease.
Hematology/oncology clinics of North America 1989;3(2):277-86.
-
1989: Farah R; Weichselbaum R R
Management of stage I and II Hodgkin's disease.
Hematology/oncology clinics of North America 1989;3(2):253-63.
-
1989: Panje W R; Dohrmann G J; Pitcock J K; Scher N; Weichselbaum R R; Sutton H G; Vokes E; Moss J
The transfacial approach for combined anterior craniofacial tumor ablation.
Archives of otolaryngology--head & neck surgery 1989;115(3):301-7.
-
1989: Vokes E E; Schilsky R L; Weichselbaum R R; Guaspari A; Guarnieri C M; Whaling S M; Panje W R
Cisplatin, 5-fluorouracil, and high-dose oral leucovorin for advanced head and neck cancer.
Cancer 1989;63(6 Suppl):1048-53.
-
1989: Rotmensch J; Atcher R W; Schlenker R; Hines J; Grdina D; Block B S; Press M F; Herbst A L; Weichselbaum R R
The effect of the alpha-emitting radionuclide lead-212 on human ovarian carcinoma: a potential new form of therapy.
Gynecologic oncology 1989;32(2):236-9.
-
1989: Vokes E E; Schilsky R L; Choi K E; Magid D M; Guarnieri C M; Whaling S M; Ratain M J; Weichselbaum R R; Panje W R
A randomized study of inpatient versus outpatient continuous infusion chemotherapy for patients with locally advanced head and neck cancer.
Cancer 1989;63(1):30-6.
-
1989: Weichselbaum R R; Beckett M A; Diamond A A
An important step in radiation carcinogenesis may be inactivation of cellular genes.
International journal of radiation oncology, biology, physics 1989;16(1):277-82.
-
1989: Pelizzari C A; Chen G T; Spelbring D R; Weichselbaum R R; Chen C T
Accurate three-dimensional registration of CT, PET, and/or MR images of the brain.
Journal of computer assisted tomography 1989;13(1):20-6.
-
1989: Magid D M; Vokes E E; Schilsky R L; Guarnieri C M; Whaling S M; Weichselbaum R R; Panje W R
A randomized study of inpatient versus outpatient continuous intravenous infusion chemotherapy: psychosocial aspects.
Selective cancer therapeutics 1989;5(3):137-45.
-
1988: Weichselbaum R R; Beckett M A; Simon M A; McCauley C; Haraf D; Awan A; Samuels B; Nachman J; Dritschilo A
In vitro radiobiological parameters of human sarcoma cell lines.
International journal of radiation oncology, biology, physics 1988;15(4):937-42.
-
1988: Schwartz J L; Rotmensch J; Giovanazzi S; Cohen M B; Weichselbaum R R
Faster repair of DNA double-strand breaks in radioresistant human tumor cells.
International journal of radiation oncology, biology, physics 1988;15(4):907-12.
-
1988: Weichselbaum R R; Beckett M A; Schwartz J L; Dritschilo A
Radioresistant tumor cells are present in head and neck carcinomas that recur after radiotherapy.
International journal of radiation oncology, biology, physics 1988;15(3):575-9.
-
1988: Schwartz J L; Rotmensch J; Beckett M A; Jaffe D R; Toohill M; Giovanazzi S M; McIntosh J; Weichselbaum R R
X-ray and cis-diamminedichloroplatinum(II) cross-resistance in human tumor cell lines.
Cancer research 1988;48(18):5133-5.
-
1988: Beckett M A; Weichselbaum R R
Southern analysis of human head and neck cancer cells for homologous sequences using yeast gamma repair genes.
Journal of surgical oncology 1988;38(4):257-60.
-
1988: Ackland S P; Schilsky R L; Beckett M A; Weichselbaum R R
Synergistic cytotoxicity and DNA strand break formation by bromodeoxyuridine and bleomycin in human tumor cells.
Cancer research 1988;48(15):4244-9.
-
1988: Weichselbaum R R; Beckett M A; Dahlberg W; Dritschilo A
Heterogeneity of radiation response of a parent human epidermoid carcinoma cell line and four clones.
International journal of radiation oncology, biology, physics 1988;14(5):907-12.
-
1988: Vokes E E; Choi K E; Schilsky R L; Moran W J; Guarnieri C M; Weichselbaum R R; Panje W R
Cisplatin, fluorouracil, and high-dose leucovorin for recurrent or metastatic head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(4):618-26.
-
1988: Weichselbaum R R; Beckett M; Diamond A
Some retinoblastomas, osteosarcomas, and soft tissue sarcomas may share a common etiology.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(7):2106-9.
-
1988: Vokes E E; Panje W R; Weichselbaum R R; Schilsky R L; Moran W J; Awan A M; Guarnieri C M
Concomitant hydroxyurea, 5-fluorouracil, and radiation therapy for recurrent head and neck cancer: early results.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 1988;98(4):295-8.
-
1988: Vokes E E; Moran W J; Awan A M; Schilsky R L; Goldman M; Sutton H G; Weichselbaum R R; Panje W R
Sequential administration of methotrexate, cisplatin, and 5-fluorouracil in multimodal therapy for locally advanced head and neck cancer.
NCI monographs : a publication of the National Cancer Institute 1988;(6):353-6.
Sign-in to see more